Antimicrobial resistance is a global threat caused by the rapid spread of multiresistant microorganisms. Antimicrobial stewardship (AS) is a coordinated intervention designed to improve the appropriate use of antimicrobials by promoting the selection of the optimal drug regimen, dose, duration of therapy and route of administration. AS programs have proved effective in reducing antimicrobial resistance, inappropriate antimicrobial use and in improving patient outcomes. Recently developed rapid diagnostic technologies in microbiology (RDTM) allows a faster and etiological diagnosis of infection and a reduction in the use of unnecessary empirical therapies. This may result in important advancement in time-critical care pathways for septic patients. Nevertheless, RDTM are costly and if not rationally positioned may consume resources and hinder the efficacy of AS programs. In this regard, Tuscany Region is engaged in designing, through a systemic approach, an effective high-quality clinical microbiological service grid. In order to develop a sustainable and equitable model for integrating diagnostic and antimicrobial stewardship we conducted a survey in the regional network of 14 microbiological laboratories. The results shows that in order to develop a sustainable service we need to improve the communication at the interface between laboratories and care unit, harmonize the time windows for processing samples and to devise a robust score for stratifying patient with suspected sepsis.

Forni, S., Toccafondi, G., Viaggi, B., Grazzini, M., D'Arienzo, S., Gemmi, F., et al. (2018). The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model. RECENTI PROGRESSI IN MEDICINA, 109(2), 133-136 [10.1701/2865.28909].

The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model

D'Andrea M. M.;
2018-01-01

Abstract

Antimicrobial resistance is a global threat caused by the rapid spread of multiresistant microorganisms. Antimicrobial stewardship (AS) is a coordinated intervention designed to improve the appropriate use of antimicrobials by promoting the selection of the optimal drug regimen, dose, duration of therapy and route of administration. AS programs have proved effective in reducing antimicrobial resistance, inappropriate antimicrobial use and in improving patient outcomes. Recently developed rapid diagnostic technologies in microbiology (RDTM) allows a faster and etiological diagnosis of infection and a reduction in the use of unnecessary empirical therapies. This may result in important advancement in time-critical care pathways for septic patients. Nevertheless, RDTM are costly and if not rationally positioned may consume resources and hinder the efficacy of AS programs. In this regard, Tuscany Region is engaged in designing, through a systemic approach, an effective high-quality clinical microbiological service grid. In order to develop a sustainable and equitable model for integrating diagnostic and antimicrobial stewardship we conducted a survey in the regional network of 14 microbiological laboratories. The results shows that in order to develop a sustainable service we need to improve the communication at the interface between laboratories and care unit, harmonize the time windows for processing samples and to devise a robust score for stratifying patient with suspected sepsis.
2018
Pubblicato
Rilevanza nazionale
Articolo
Esperti anonimi
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
Settore BIO/19 - MICROBIOLOGIA GENERALE
Italian
Anti-Infective Agents; Drug Resistance, Microbial; Humans; Italy; Laboratories; Sepsis; Antimicrobial Stewardship
http://www.recentiprogressi.it/r.php?v=2865&a=28909&l=333350&f=allegati/02865_2018_02/fulltext/12_Com Brevi - Forni.pdf
Forni, S., Toccafondi, G., Viaggi, B., Grazzini, M., D'Arienzo, S., Gemmi, F., et al. (2018). The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model. RECENTI PROGRESSI IN MEDICINA, 109(2), 133-136 [10.1701/2865.28909].
Forni, S; Toccafondi, G; Viaggi, B; Grazzini, M; D'Arienzo, S; Gemmi, F; Vannucci, A; Tulli, G; Rossolini, Gm; Pecile, P; Cusi, Mg; Cresti, S; Barnini...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
LE-41, Forni Recenti progressi in Medicina_bozze 2018.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 60.81 kB
Formato Adobe PDF
60.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/226305
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact